☰

Salman M. Hyder

Affiliations: 
University of Missouri - Columbia, Columbia, MO, United States 
Area:
Molecular Biology
Google:
"Salman Hyder"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
James Lamar Wittliff post-doc (Chemistry Tree)

Children

Sign in to add trainee
Candace E. Carroll grad student 2009 University of Missouri - Columbia
Benford Mafuvadze grad student 2012 University of Missouri - Columbia

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liang Y, Nephew KP, Hyder SM. (2023) Cholesterol Biosynthesis Inhibitor RO 48-8071 Suppresses Growth of Epithelial Ovarian Cancer Cells in Vitro and In Vivo. Journal of Cancer Science and Clinical Therapeutics. 7: 1-8
Liang Y, Besch-Williford C, Hyder SM. (2022) The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth. Breast Cancer Research and Treatment. 192: 53-63
Berke TP, Slight SH, Hyder SM. (2022) Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer. Oncotargets and Therapy. 15: 23-30
Liang Y, Besch-Williford C, Cook MT, et al. (2019) APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice. Breast Cancer (Dove Medical Press). 11: 249-259
Liang Y, Besch-Williford C, Belenchia A, et al. (2019) SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine Journal of the Endocrine Society. 3
Liang Y, Mafuvadze B, Besch-Williford C, et al. (2018) A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts. Breast Cancer (Dove Medical Press). 10: 53-67
Liang Y, Goyette S, Hyder SM. (2017) Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells. Breast Cancer (Dove Medical Press). 9: 487-494
Goyette S, Liang Y, Mafuvadze B, et al. (2017) Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro. Breast Cancer (Dove Medical Press). 9: 347-357
Cook MT, Liang Y, Besch-Williford C, et al. (2017) Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells. Breast Cancer (Dove Medical Press). 9: 9-19
Cook MT, Liang Y, Besch-Williford C, et al. (2017) Abstract 4914: Luteolin inhibits metastasis of triple-negative breast cancer cells to the lungs Cancer Research. 77: 4914-4914
See more...